Market Cap 3.88B
Revenue (ttm) 1.53B
Net Income (ttm) 312.44M
EPS (ttm) N/A
PE Ratio 11.94
Forward PE 12.73
Profit Margin 20.37%
Debt to Equity Ratio 0.51
Volume 1,320,580
Avg Vol 1,324,770
Day's Range N/A - N/A
Shares Out 66.31M
Stochastic %K 92%
Beta -0.10
Analysts Strong Sell
Price Target $81.00

Company Profile

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area wi...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 978 671 8001
Fax: 978 671 8860
Address:
201 Burlington Road, South Building, Bedford, United States
Iightning
Iightning Dec. 4 at 9:50 PM
1ightning® Premium Options Alert (Actionable) Ticker: $LNTH Contract: Dec 19 $62.5C Entry: 1.82 Exit: 2.88 Return: +57.64% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
WhoKnocks
WhoKnocks Dec. 4 at 8:35 PM
0 · Reply
Live2ride
Live2ride Dec. 4 at 8:17 PM
$LNTH Now let's go fill that gap at $69 by EOY.
0 · Reply
Mahdinur
Mahdinur Dec. 4 at 6:54 PM
0 · Reply
Cmhatwell
Cmhatwell Dec. 4 at 6:53 PM
$GRI people get ready! also take a peek at $LNTH which has 3 pdufa dates in 2026
0 · Reply
TradingFUD
TradingFUD Dec. 4 at 3:02 PM
$LNTH Yesterday Eisai released data. Which supports the growth of Neuraceq. This is the data we needed to confirm Lantheus BULL THESIS! To be eligible for treatment with Leqembi, a patient must have a PET scan. Leqembi needs Neuraceq! The demand for Leqembi (lecanemab) has significantly increased the use of Neuraceq. $BIIB $XBI $LLY
0 · Reply
Iightning
Iightning Dec. 4 at 5:31 AM
1ightning® Premium Options Alert (Actionable) Ticker: $LNTH Contract: Dec 19 $60C Entry: 2.08 Exit: 3.31 Return: +59.39% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Live2ride
Live2ride Dec. 3 at 8:12 PM
$LNTH This $60 resistance is a bitch. How about an end of day push with some better volume to get us back into the 60's once and for all. Ain't too proud to beg!
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Dec. 3 at 4:08 PM
0 · Reply
Iightning
Iightning Dec. 3 at 9:34 AM
1ightning® Premium Options Alert (Actionable) Ticker: $LNTH Contract: Dec 19 $155C Entry: 9.95 Exit: 13.70 Return: +37.72% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Latest News on LNTH
Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:09 PM EDT - 4 months ago

Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript


Lantheus (LNTH) Q2 Revenue Falls 4%

Aug 6, 2025, 3:11 PM EDT - 4 months ago

Lantheus (LNTH) Q2 Revenue Falls 4%


Lantheus Holdings: Reassessing The Buy Thesis

Aug 6, 2025, 10:09 AM EDT - 4 months ago

Lantheus Holdings: Reassessing The Buy Thesis


Iightning
Iightning Dec. 4 at 9:50 PM
1ightning® Premium Options Alert (Actionable) Ticker: $LNTH Contract: Dec 19 $62.5C Entry: 1.82 Exit: 2.88 Return: +57.64% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
WhoKnocks
WhoKnocks Dec. 4 at 8:35 PM
0 · Reply
Live2ride
Live2ride Dec. 4 at 8:17 PM
$LNTH Now let's go fill that gap at $69 by EOY.
0 · Reply
Mahdinur
Mahdinur Dec. 4 at 6:54 PM
0 · Reply
Cmhatwell
Cmhatwell Dec. 4 at 6:53 PM
$GRI people get ready! also take a peek at $LNTH which has 3 pdufa dates in 2026
0 · Reply
TradingFUD
TradingFUD Dec. 4 at 3:02 PM
$LNTH Yesterday Eisai released data. Which supports the growth of Neuraceq. This is the data we needed to confirm Lantheus BULL THESIS! To be eligible for treatment with Leqembi, a patient must have a PET scan. Leqembi needs Neuraceq! The demand for Leqembi (lecanemab) has significantly increased the use of Neuraceq. $BIIB $XBI $LLY
0 · Reply
Iightning
Iightning Dec. 4 at 5:31 AM
1ightning® Premium Options Alert (Actionable) Ticker: $LNTH Contract: Dec 19 $60C Entry: 2.08 Exit: 3.31 Return: +59.39% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Live2ride
Live2ride Dec. 3 at 8:12 PM
$LNTH This $60 resistance is a bitch. How about an end of day push with some better volume to get us back into the 60's once and for all. Ain't too proud to beg!
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Dec. 3 at 4:08 PM
0 · Reply
Iightning
Iightning Dec. 3 at 9:34 AM
1ightning® Premium Options Alert (Actionable) Ticker: $LNTH Contract: Dec 19 $155C Entry: 9.95 Exit: 13.70 Return: +37.72% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
StockConsultant
StockConsultant Dec. 2 at 1:46 PM
$LNTH Lantheus stock, watch for an upside gap breakout at https://stockconsultant.com/?LNTH
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Dec. 2 at 11:46 AM
0 · Reply
Iightning
Iightning Dec. 1 at 11:45 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $LNTH **Contract:** Dec 19 $60C **Entry:** 1.79 **Exit:** 3.52 **Return:** **+97.41% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Drashkawisha
Drashkawisha Dec. 1 at 10:56 AM
$LNTH The "Smart Money" Trade. While retail panics over management changes, look at the facts: 1. Valuation: Trading at ~10x FWD P/E with $780M Cash pile. 2. Growth: Beat & Raise quarter despite the noise. 3. Catalyst: March 2026 is a Double-Header. • Mar 6: Pylarify optimization • Mar 29: LNTH-2501 Approval The "Multiple Bottom" at $48 is concrete. I'm collecting shares here for the re-rating. Management appointment will be the match that lights this powder keg.
0 · Reply
Drashkawisha
Drashkawisha Dec. 1 at 7:19 AM
$LNTH Question for the longs here doing deep DD: I see the "Beat & Raise" and the cash pile, but I'm trying to reconcile the massive insider selling (-82%) with the heavy institutional buying. Also, regarding March 2026: Does anyone have clarity on the revenue impact difference between the Pylarify sNDA (Mar 6) vs. the new LNTH-2501 NDA (Mar 29)? Is the market pricing in the management exit too harshly, or is there a skeleton in the closet I'm missing? Would appreciate serious inputs
1 · Reply
Iightning
Iightning Nov. 26 at 2:34 AM
1ightning® Options Trade Alert (Actionable) | Buy $LNTH Dec 19 $58 Call | Enter: $2.46 Exit: $3.40 | Profit: 37.97% ROI | https://1ightning.com
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Nov. 26 at 1:29 AM
$LNTH we going to $99 very soon
0 · Reply
TPTradingCo
TPTradingCo Nov. 25 at 5:40 PM
$LNTH might just be that time of year, folks
0 · Reply
Iightning
Iightning Nov. 25 at 12:40 PM
1ightning® Options Trade Alert (Actionable) | Buy $LNTH Dec 19 $58 Call | Enter: $2.46 Exit: $3.40 | Profit: 37.97% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 1:35 AM
1ightning® Options Trade Alert (Actionable) | Buy $LNTH Dec 19 $58 Call | Enter: $2.46 Exit: $3.40 | Profit: 37.97% ROI | https://1ightning.com
0 · Reply
Estimize
Estimize Nov. 24 at 12:01 PM
Wall St is expecting 1.19 EPS for $LNTH Q4 [Reporting 02/19 BMO] http://www.estimize.com/intro/lnth?chart=historical&metric_name=eps&utm_co
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Nov. 23 at 11:55 PM
$LNTH BIG THINGS FOR MUNGER WORLD
0 · Reply